Andreas E. Albers

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications

T-Shaped Stibenium(III) Cation: Hydrostibination Without Sb─H Bond.

T-Shaped Stibenium(III) Cation: Hydrostibination Without Sb─H Bond.

Journal: Angewandte Chemie (International ed. in English)
Published: April 28, 2026

Identifying Truly HPV-Driven Head and Neck Squamous Cell Carcinoma by QuantiGene-Molecular-Profiling-Histology Assay Allows for More Precise Prognosis Prediction.

Identifying Truly HPV-Driven Head and Neck Squamous Cell Carcinoma by QuantiGene-Molecular-Profiling-Histology Assay Allows for More Precise Prognosis Prediction.

Journal: International journal of molecular sciences
Published: November 01, 2024

Predicting Lewis Acidity: Machine Learning the Fluoride Ion Affinity of p-Block-Atom-Based Molecules.

Predicting Lewis Acidity: Machine Learning the Fluoride Ion Affinity of p-Block-Atom-Based Molecules.

Journal: Angewandte Chemie (International ed. in English)
Published: January 19, 2024

Integration and viral oncogene expression of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma and gastric cancer.

Integration and viral oncogene expression of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma and gastric cancer.

Journal: Journal of medical virology
Published: January 18, 2023

Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer.

Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer.

Journal: Viruses
Published: October 30, 2022

Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches.

Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches.

Journal: Pharmaceutics
Published: June 30, 2022

Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.

Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.

Journal: Cells
Published: February 11, 2021

Current Status of Human Papillomavirus-Related Head and Neck Cancer: From Viral Genome to Patient Care.

Current Status of Human Papillomavirus-Related Head and Neck Cancer: From Viral Genome to Patient Care.

Journal: Virologica Sinica
Published: January 21, 2021

Impact of Smoking on the Survival of Patients With High-risk HPV-positive HNSCC: A Meta-analysis.

Impact of Smoking on the Survival of Patients With High-risk HPV-positive HNSCC: A Meta-analysis.

Journal: In vivo (Athens, Greece)
Published: October 04, 2020

Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer.

Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer.

Journal: Oncotarget
Published: June 06, 2020

Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck.

Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck.

Journal: International journal of biological sciences
Published: April 15, 2020

Immunotherapeutics for head and neck squamous cell carcinoma stem cells.

Immunotherapeutics for head and neck squamous cell carcinoma stem cells.

Journal: HNO
Published: January 31, 2020
Showing 1-12 of 76

Last Updated: 09/26/2026